PHYSIOLOGICAL REVIEWS   Vol. 78 No. 3 July 1998, pp. 763-781
Copyright ©1998 by the American Physiological Society

The Cytoskeleton and Cell Signaling: Component Localization and Mechanical Coupling

PAUL A. JANMEY

Experimental Medicine Division, Brigham and Women's Hospital, Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts

I. INTRODUCTION
II. LOCALIZATION OF ENZYMATIC ACTIVITIES TO THE CYTOSKELETON
    A. Glycolytic Enzymes
    B. Protein Kinases
    C. Lipid Kinases and Phospholipases
    D. GTPases
III. THE CYTOSKELETON AND INTRACELLULAR CALCIUM
IV. ION CHANNELS AND TRANSPORTERS
V. SENSING AND TRANSMITTING MECHANICAL STRESSES
VI. THE CYTOSKELETON AND APOPTOSIS
VII. CYTOSKELETAL ROLE IN SIGNALING TO THE NUCLEUS
VIII. CONCLUSIONS
REFERENCES

	ABSTRACT

Top References

Janmey, Paul A. The Cytoskeleton and Cell Signaling: Component Localization and Mechanical Coupling. Physiol. Rev. 78: 763-781, 1998.  The three-dimensional intracellular network formed by the filamentous polymers comprising the cytoskeletal affects the way cells sense their extracellular environment and respond to stimuli. Because the cytoskeleton is viscoelastic, it provides a continuous mechanical coupling throughout the cell that changes as the cytoskeleton remodels. Such mechanical effects, based on network formation, can influence ion channel activity at the plasma membrane of cells and may conduct mechanical stresses from the cell membrane to internal organelles. As a result, both rapid responses such as changes in intracellular Ca²⁺ and slower responses such as gene transcription or the onset of apoptosis can be elicited or modulated by mechanical perturbations. In addition to mechanical features, the cytoskeleton also provides a large negatively charged surface on which many signaling molecules including protein and lipid kinases, phospholipases, and GTPases localize in response to activation of specific transmembrane receptors. The resulting spatial localization and concomitant change in enzymatic activity can alter the magnitude and limit the range of intracellular signaling events.

	I. INTRODUCTION

Top Next References

The cytoskeleton is a filamentous network of F-actin, microtubules, and intermediate filaments (IFs) composed of one of three chemically distinct subunits, actin, tubulin, or one of several classes of IF protein (20, 191). Modulation of the cytoskeletal network changes the mechanical properties of the cell that are essential for functions such as locomotion (151, 209) and cytokinesis (61). The filamentous cytoskeletal network also provides a scaffolding on which motor proteins such as kinesin, dynein, and myosin can translocate to move organelles or generate internal stress. The transmembrane receptors and intracellular signals producing cytoskeletal changes in response to extracellular stimuli have been extensely studied and are the subject of several recent reviews (42, 44, 209, 214, 253).

The cytoskeleton undoubtedly regulates cellular mechanics, but there are probably other important functions of this ubiquitous and extensive organelle. Independent of its mechanical strength, the filaments of the cytoskeleton form a continuous, dynamic connection between nearly all cellular structures, and they present an enormous surface area on which proteins and other cytoplasmic components can dock. To put this feature in perspective, the surface area of the plasma membrane of a 20-µm-diameter cell is on the order of 700 µm², and the total surface of all cytoplasmically disposed lipid bilayers is ~10 times this area. In contrast, the total surface area of a typical concentration of 10 mg/ml F-actin in such a 20-µm cell is 47,000 µm², and an approximately equal area is presented by microtubules and IFs. This large surface, along with the high negative electrostatic charge density of all cytoskeletal filaments (107, 212, 213), presents a strong potential for localization and immobilization of cytoplasmic components.

On one hand, some proteins bind to the cytoskeleton to alter its assembly in response to cellular signals. On the other hand, probably hundreds of proteins copurify with the cytoskeleton of detergent-permeabilized cells, often to an extent that depends on activation of specific cellular signals. Many such proteins have been shown to bind purified F-actin or other cytoskeletal filaments in vitro with affinities characterized by micromolar dissociation constants. Because the cytoplasmic concentration of actin and other cytoskeletal filaments is on the order of 10-100 µM, a major fraction of such proteins would be expected to bind the cytoskeleton in vivo.

With regard to the complexity of the cytoskeleton, the intricate association of one filament type with another, and the relatively high concentration of the cytoskeletal proteins, various criteria have been used to define instances where the cytoskeleton binds or otherwise alters elements of signal transduction pathways. In many cases, linkage of a signaling molecule to the cytoskeleton is detected by sedimentation from detergent-permeabilized cell extracts under conditions where it would, in the absence of the cytoskeleton, remain in the supernatant. Such data are often supplemented by finding that the coprecipitation with the cytoskeleton depends on whether the cell is activated by specific agonists, or that selective disruption of cytoskeletal elements alters its solubility. Whether coprecipitation depends only on proteins of the cytoskeleton is often difficult to ascertain because complexes such as focal adhesions (29), cell-cell junctions (142), and caveoli (53, 135, 136, 171, 246) appear to be sites involving both cytoskeletal proteins and membrane lipids where multiple signaling molecules concentrate.

The influence of cytoskeletal structures on signaling in vivo is often detected by the effects of specific agents, such as cytochalasin, colchicine, or acrylamide, that selectively disrupt actin filaments, microtubules, and IFs, respectively. Extending such relatively indirect evidence is an increasing body of data that identifies binding between elements of signaling pathways, including both receptors and cytoplasmic proteins, with specific cytoskeletal proteins using both biochemical and genetic methods. Such specifically defined interactions are emphasized throughout this text.

Among the components localized to the cytoskeleton are ribosomes and RNA. Except for a few examples of proteins involved in the translational machinery that interact specifically with cytoskeletal filaments, the reader is referred elsewhere for recent reviews of this important field (10, 99, 173). Transmembrane protein complexes that link cells to each other or to the extracellular matrix not only link the cell membrane to the actin or IF cytoskeleton but also localize and activate signaling molecules that ultimately lead to changes in cell structure and gene expression. Signaling events at these membrane sites have received several excellent recent reviews to which the reader is referred for detailed discussion (5, 10, 15, 38, 226, 245).

This review focuses on those aspects of signal transduction that depend on the unique capacity of the cytoskeleton to form a continuous three-dimensional network. One consequence of network formation is the establishment of an elastic structure by which mechanical stimuli can be sensed and transmitted. Such a mechanical continuity is likely to be required for cells such as endothelial cells to respond to fluid shear stress, as reviewed in References 48 and 49. Another consequence of polymerization and network formation is the potential for spatial segregation either to prevent or enhance the reaction of cytoskeleton-associated enzymes with their targets. The chemical and physical properties of the cytoskeleton suggest that it may have subtle and important effects on the way in which information is passed from points at the cell membrane to structures deep within the cytoplasm or the nucleus (62, 63).

	II. LOCALIZATION OF ENZYMATIC ACTIVITIES TO THE CYTOSKELETON

Top Previous Next References

Among the longest known and best-characterized cytoskeleton-binding proteins are glycolytic enzymes (4). Although these enzymes are not usually considered as central to signal transduction pathways, their localization to cytoskeletal filaments, along with some of their substrates (72), presents a model by which signal sequestration mechanisms may be interpreted. In some cases, glycolytic enzymes may themselves be important mediators of cell response and function. The fundamental idea (reviewed in Refs. 147, 165) is that some key glycolytic enzymes, in particular, aldolase, glyceraldehyde-3-phosphate dehydrogenase, lactate dehydrogenase (LDH), and phosphofructokinase-1, are sequestered near the hydrated surface of actin filaments (41) within a complex layer containing also some of their substrates (see Fig. 1). In some cases, binding to F-actin also affects enzymatic activity. The direct relevance of these interactions to glycolysis in vivo has recently been demonstrated by specific localization in vivo of aldolase with actin stress fibers (166), the colocalization of glucokinase with cellular actin (154), and the close correlation between the changes in the actin filament network structure and metabolic rates during the cell cycle (17) and in cases of experimental manipulation of cytoskeletal structure (221).

View larger version (37K): [in this window] [in a new window]   FIG. 1.   Schematic model of protein sequestration at the hydrated surface of an actin filament. [Derived from Clegg (41).]

A striking feature of cytoskeletal localization of some glycolytic enzymes is that they are not entirely specific to actin filaments. Phosphofructokinase, for example, also binds to and is inhibited by tubulin and microtubules (124, 237), and glyceraldehyde-3-phosphate dehydrogenase binds all three filament systems. Although such promiscuous binding may suggest nonspecific, biologically irrelevant association, the accruing evidence that such associations occur in vivo and have metabolic consequences, along with recent demonstration that in some cases single point mutations (238) can ablate cytoskeletal binding, argue strongly for the importance of this mode of cytoskeletal localization. The concepts developed to explain enzyme sequestration and metabolic channeling emphasize the importance of multiple weak interactions at a surface, in addition to the tight, highly ordered protein-protein bonds more commonly considered to provide specificity to biologically relevant binding events. These same concepts may likewise be crucial to placing the multiple complex associations of signaling factors with the cytoskeleton in a physiological context.

2. Protein kinase C and cAMP-dependent kinase-actin interactions

Some protein kinase C (PKC) isotypes bind to actin filaments, and this binding appears to be essential for the translocation of PKC- to the nucleus of NIH 3T3 fibroblasts treated with phorbol ester (

Some of the same signals that promote cytoskeletal binding of protein kinases also recruit phospholipases and lipid kinases to the cytoskeleton. In platelets, thrombin stimulation causes the association of phospholipase A₂ (2), phosphatidylinositol (PI) 3-kinase, PI 4-kinase, diacylglycerol (DAG) kinase, and phospholipase C (PLC) to the cytoskeleton during the period when a massive polymerization of actin occurs (7, 84, 96, 156). Phosphatidylinositol 4-phosphate (PIP) 5-kinase and PLC appear to localize before the other enzymes, and the specific activities of both PI 3- and 4-kinases are higher in the cytoskeletal fraction (84). Much of the PLC activity localized to the cytoskeleton is the PLC- isoform that binds the actin cytoskeleton by its COOH-terminal SH2 domain (9, 169), whereas the isolated SH3 domain is not itself a direct link to filamentous actin (232). The membrane-bound G protein-coupled isoform (PLC-) also depends on the actin cytoskeleton for its localization and coupling to the G protein (234). Phosphatidylinositol 3-kinase is reversibly recruited to the ADP-stimulated platelet cytoskeleton by a mechanism not dependent on Rho protein and probably distinct from the thrombin-signaling cascade (71). Phosphoinositide (PPI) kinase, DAG kinase, and PLC activities also localize to the cytoskeleton of A 431 cells after stimulation by EGF (168).

Localization of PI 3-kinase to the centrosome and other intracellular structures depends on its binding to tubulin (111, 112). In particular, there appears to be an insulin-stimulated binding of PI 3-kinase to -tubulin that may be involved in regulating microtubule responses to insulin and other stimuli (112). A notable aspect of the recruitment of inositol lipid kinases and phospholipases is that the substrates for these enzymes also copurify with the cytoskeleton, especially after cell stimulation (96, 236).

Not only are lipid kinases and lipases localized to the cytoskeleton, but their activities are altered by a number of cytoskeletal proteins, especially those associated with actin. Phospholipase C- is strongly inhibited by profilin (81, 82) and gelsolin (8), and the inhibition by profilin is overcome when PLC- is tyrosine phosphorylated (81). Similarly, PLC-1 and PLC-1 are inhibited by myristoylated, alanine-rich C-kinase substrate (MARCKS) protein by a mechanism involving redistribution of lipid packing by MARCKS that is reversed by PKC (77). In contrast, the microtubule binding protein tau acts as a cofactor with arachidonate to stimulate PLC- activity (101), and a peptide based on the sequence of PLC-, homologous to the PPI binding motif in gelsolin (249), strongly stimulates PLC- activity (199-201). Opposing effects on phospholipase D (PLD) activity are produced by gelsolin (208), which stimulates, and fodrin (139), which inhibits, this enzyme. Lipid kinase activity is also altered by actin-binding proteins. Profilin and gelsolin, which inhibit PLC-, both stimulate PI 3-kinase activity (202). A conjunction of these effects in vivo would lead to an upregulation of phosphorylated inositol lipids when these proteins are bound to PPIs at times when phosphoinositide turnover is stimulated.

The numerous effects of PPI-regulated cytoskeletal proteins on inositol lipid kinases suggest many possibilities for stimulation or inhibition of lipid-cytoskeletal complexes at sites such as focal adhesions. Several proteins that make up the complexes linking activated integrins to the cytoskeleton, including talin (113, 215), vinculin (75), and -actinin (65, 66), bind PIP₂ and in some cases are activated by this lipid to bind F-actin. At the same time, activated integrins recruit PIP 5-kinase and strongly increase cellular PIP₂ levels (149). A mechanism in which initial formation of PPIs by kinases activated at specific transmembrane receptors recruits cytoskeleton-membrane linkers that also enhance lipid kinase activity would lead to stimulation of these assemblies at highly localized sites. A similar mechanism may also affect binding of PIP₂-bound ezrin/radixin/moesin-related proteins (158) to their transmembrane targets such as intracellular adhesion molecules (94) or CD44 (97).

The regulation of cytoskeletal structure, in particular the various forms of actin-based cytoskeleton, has been shown in many cases to be directed by small GTPases of the rho family. This regulation has been the subject of recent reviews (211, 214). The focus of this section is not on how such proteins regulate the cytoskeleton, but on instances in which cytoskeletal localization of GTPases may function in transduction of their signals to other cellular targets.

	III. THE CYTOSKELETON AND INTRACELLULAR CALCIUM

Top Previous Next References

Several lines of evidence point to a direct link between cytoskeletal structure and intracellular Ca²⁺ concentration ([Ca²⁺]) levels, and a number of different mechanisms have been proposed. Treatment of cells with cytochalasins that disrupt the actin cytoskeleton can lead to increased intracellular [Ca²⁺]. This effect may be mediated by increased PPI metabolism, consistent with the cytoskeletal dependence of phospholipases, cited above, that produce inositol 1,4,5-trisphosphate (IP₃) and subsequent release of [Ca²⁺] from intracellular stores (233). On the other hand, some aspects of IP₃-dependent Ca²⁺ release require an intact actin and microtubule system, as shown by the inhibitory effects of both cytochalasin and colchicine on IP₃-dependent Ca²⁺ release in saponin-permeabilized platelets (25). The latter result is consistent with studies of Ca²⁺ release in permeabilized hepatocytes which suggest that the cytoskeleton is required for luminal communication between intracellular stores to allow maximal release of Ca²⁺ by IP₃ (87). The assumption that intracellular Ca²⁺ is released entirely by independent IP₃ receptor-containing internal organelles has been challenged by findings that the IP₃ receptor of intact hepatocytes is primarily at the plasma membrane and that release from intracellular stores is achieved by a mechanical link from IP₃-sensitive channels at the plasma membranes to ryanodine-sensitive channels in the endoplasmic reticulum mediated by the cytoskeleton (118).

A direct effect of the cytoskeleton, and F-actin in particular, on Ca²⁺ release is supported by the finding that intracellular release of Ca²⁺ in neutrophils stimulated by aggregated IgG binding to the Fc receptor is not mediated by IP₃ but is inhibited by cytochalasin (181). In contrast, the IP₃-dependent release stimulated by fMLP is unaffected by cytochalasin (181). A role for actin in signaling from the Fc receptor is further supported by the finding that the target of bromophenacyl bromide, a potent inhibitor of leukocyte activation and Fc receptor-mediated Ca²⁺ release, is L-plastin, an actin filament binding and bundling protein (182). How the function of plastin, itself a Ca²⁺-dependent protein, relates to Ca²⁺ release is not yet known. A very recent result suggests that the actin cytoskeleton may not only regulate Ca²⁺ release but may itself be part of the intracellular Ca²⁺ store (120). Despite the large differences in bulk concentrations of intracellular free Mg²⁺ and Ca²⁺, the probability that actin subunits near the cell membrane may bind Ca²⁺ and then incorporate into filaments would allow accumulation of several micromolar Ca²⁺ in the nearly millimolar pool of actin. This pool of Ca²⁺ would be released when the actin filaments depolymerize or treadmill, and even global changes of several hundred nanomolar appear to be realistically attainable. A similar release may also occur from microtubules and could possibly relate to observations that microtubule depolymerization can activate Ca²⁺-dependent enzymes such as myosin kinases leading to increased actomyosin contractility (115, 183).

	IV. ION CHANNELS AND TRANSPORTERS

Top Previous Next References

Among the best-characterized roles for the cytoskeleton in cell signaling involves the regulation of transmembrane ion flux (47, 52). Most studies have employed drugs that selectively stabilize or destabilize either F-actin or microtubules, with resulting effects on specific ion channels measured either in whole cells or in single channels in a patch clamp. Although a direct binding of specific cytoskeletal proteins to individual channel proteins cannot be demonstrated by such studies, recent work in which exogenous purified actin has been added to the cytoplasmic side of channels excised from the cell membrane have in numerous cases directly confirmed an effect of cytoskeletal filaments.

One indirect way that cytoskeletal changes alter ion conductivity is by altering the delivery, expression, or clustering of channel proteins at the plasma membrane (64, 128, 203). Lateral mobility of channels in the plasma membrane may be limited by interactions either with the three-dimensional cytoskeleton or the two-dimensional spectrin/fodrin-actin network underlying the plasma membrane lipid bilayer, as suggested by reports of channel proteins interacting with ankyrin (51, 207) (see Table 1). More direct effects on channel conductance, open probability, or inactivation have been found in several cases where either the actin or microtubule system has been altered. Some of these results are summarized in Table 1. Although it is probably premature to infer general patterns in these studies, there appears to be a trend to activate Na⁺ channels by actin-destabilizing drugs such as cytochalasins and to block this effect by the actin-stabilizing drug phalloidin or by adding F-actin itself. This is certainly not a strict rule, since short actin filaments activate rather than prevent Na⁺ channel opening in some cases (16), and a consensus for how such effects takes place has not been reached. In contrast, K⁺ channels are inactivated by a disrupted actin cytoskeleton caused either by cytochalasin or by the loss of expression of the major actin cross-linking protein ABP280 (33). Chloride channels, like Na⁺ channels, are more frequently activated by cytochalasin and inactivated by increasing actin cross linking, but again, there are exceptions to a simple interpretation, since F-actin itself can also activate some Cl channel activity.

In several cases where the effects of cytochalasin have been compared with those of nocodazole or colchicine, microtubule disruption has not been found to affect Na⁺, K⁺, or Cl channels. However, disruption of microtubules has been reported to enhance the activity of both Ca²⁺ (73, 218) and Cl (92, 109) channels in some cases.

An intriguing hypothesis for how disruption of actin may activate K⁺ channels is by release of protein kinase A (PKA) bound to the actin (175). In this model, the regulation depends not only on a link of actin to the receptor, but on changing localization of a cytoskeleton-bound signaling kinase, as discussed in section IIB.

Some Ca²⁺ channels are inactivated by cytochalasin, and the effect is blocked by phalloidin. However, stretch-activated Ca²⁺ influx can be activated by cytochalasin and inhibited by F-actin. Moreover, there are several reports of microtubule disruption also altering Ca²⁺ channel activity (73, 218), with a strong enhancement in one case that was not achieved by cytochalasin. A scenario derived from Reference 78 for how actin filaments may affect Ca²⁺ influx resulting from mechanical stresses is shown in Figure 2. In this model, application of a mechanical stress at the plasma membrane of a resting cell causes deformation of channels in the plasma membrane that results in Ca²⁺ influx. In these cells, a sustained mechanical stress leads to assembly of two distinct structures: contractile elements containing actin filaments that create an opposing force and an elastic network that resists subsequent application of the external stress. As the stress is transmitted to the newly formed three-dimensional cytoskeleton, it is directed away from the plasma membrane, and the deformation of membrane elements near the site of force is now insufficient to activate Ca²⁺ influx.

View larger version (19K): [in this window] [in a new window]   FIG. 2.   Formation of contractile actin-containing bundles at sites of mechanical stress and its relation to regulating stretch-activated ion transport. [From Glogauer et al. (78).]

One context in which mechanical effects on the cytoskeleton regulate ion fluxes is volume regulation after osmotic stress. Although the elastic modulus of the cytoskeleton is probably too low (1,000-10,000 Pa in some cell types and lower in others) to prevent volume changes caused by osmotic imbalance (10,000 Pa/mosM), its presence as an elastic element provides the cell with a countering tension and a memory of the undeformed state, at least for the time that the cross-linked cytoskeleton remains intact. It is not surprising, therefore, that the cytoskeleton affects ion transport in volume regulation (33, 43, 92, 129, 193). Among the clearest evidence for a mechanical function comes from the finding that melanoma cells containing approximately normal amounts of cytoskeletal filaments and ion channels, but lacking the cross-linking protein ABP280 that provides rigidity to the cell cortex, fail to volume regulate under hypotonic conditions. Transfection of ABP280 to these cells restores this capacity (33).

Whether the effects of the cytoskeleton on ion channel activity are a direct mechanical effect or an indirect effect due to such changes as regulation of kinases sequestered at the cytoskeleton remains a controversial issue. There are reports that the cytoskeleton has no effect on channel activity and reports that ion conductance through channels within a lipid bilayer can be altered by bilayer dilation in the absence of any internal network (162). On the other hand, there are intriguing hypotheses that actin filaments and microtubules could directly transmit ion fluxes because of their polyelectrolyte nature and the presence of a condensed counterion cloud (133). Although such effects appear plausible from a physical-chemical perspective, demonstrating their importance in biological ion signaling remains a challenge for future work.

	V. SENSING AND TRANSMITTING MECHANICAL STRESSES

Top Previous Next References

A primary signal to many cell types is mechanical. Senses of hearing and touch are initiated by forces rather than molecules impinging on the cell surface that are later transduced to the biochemical reactions leading to acute cellular responses. In addition, acute or sustained application of forces such as the shear stress produced by vascular fluid flow often leads to remodeling of cell morphology or to expression of specific genes (45, 106, 220). The cytoskeleton is not the only structure capable of detecting and transducing such stimuli, and a number of membrane-bound molecules such as phospholipase A₂ (125) and alamethicin (162) can directly react to stresses within the lipid bilayer. However, for mechanical transduction to the cell interior, a three-dimensional elastic structure is required. In all these cases, signaling depends on elastic coupling between the site where the forces are applied and the potentially distant point at which the first biochemical change occurs (144). Recent elegant work has shown a direct effect of forces on the structure and function of individual molecules (14). Strong cases have been made for effects of tension in axonal development (93, 231) and for specific stress-induced acute responses (48, 49) and gene regulatory elements in endothelial cells (178). This section focuses on a few examples of such mechanical signaling and attempts to provide a context by which to evaluate how the cytoskeleton contributes to these signals.

One role of the cytoskeleton in mechanical stress-induced signaling is a direct elastic coupling from the site of the force applied at the cell membrane to the site of ultimate response, at a distant plasma membrane site, an internal organelle, or within the nucleus. The case for such a mechanical continuity has recently received strong support from findings of nuclear deformation caused by application of force at the plasma membrane (85, 144). In these studies, compressive (85) or elongational forces (144) applied to the plasma membrane of surface-attached cells led immediately to displacement of internal organelles (144) and deformation of the nucleus. Nuclear deformation was preserved in cells treated by both cytochalasin and nocodazole, suggesting that IFs alone are capable of linking the nucleus to the cell membrane, as has been proposed for many years (reviewed in Refs. 223, 224). Remarkably, although the elastic modulus of the nucleus is nearly 10 times higher than that of the cytoplasm in control cells, destabilization of the cytoskeleton by cytochalasin or acrylamide (an IF destabilizer) lowers the stiffness of the nucleus, suggesting that cytoskeletal proteins may have a direct effect on nuclear structure. The relation between forces and cell functions mediated by the cytoskeleton has recently been extensively reviewed in terms of a theory emphasizing the analogy between cell structure and constructs combining elastic continuity with internal stress called tensegrity elements (104, 105).

Alternative models for responses to mechanical signals arise from evidence that signaling enzymes such as protein kinases (18) or lipid kinases and hydrolases (21), which may or may not be bound to the cytoskeleton, alter their activation in response to mechanical stress. In the latter case, the initiating event may require the cytoskeleton, but the proximal signaling events are mediated by soluble messengers similar or identical to those generated by biochemical first messengers. There is no necessary contradiction in these results, and as in most cellular signaling pathways, a number of distinct, interrelated signals may achieve the same outcome or modulate each other's functions.

One example of the interplay between mechanical and chemical messages is provided by studies of signaling by integrin-based focal adhesion sites (29, 39). Binding of integrins by appropriate extracellular ligands is a necessary part of establishing an adhesive contact, but occupation of the extracellular ligand binding site is not sufficient to construct a normal link between the membrane and the cytoskeleton. What is also apparently needed is mechanical tension (103). An early demonstration of this requirement was made by applying shear forces to beads bearing integrin binding peptides (239). Applying elongational stresses on collagen-coated beads bound to the dorsal cell surface actively promotes the assembly of actin stress fibers (Fig. 2) (78), and the strength of the membrane-cytoskeleton links depends on the rigidity of the extracellular material to which the cell is attached (37). These results support the remarkable idea that mechanical tension, possibly controlled by such factors as activation of myosin by rho and its downstream kinase targets, not only pulls the cytoskeleton against an already established adhesion site, but contributes to construct the focal adhesion site in the first place (29, 39).

How the cytoskeleton senses and responds to tension generated at adhesion sites is not known, and one hypothesis is that the structure of the cell in general and at these sites in particular is governed by the balance between load-bearing and tension-generating elements (105). In this case, altering one of these elements could produce large-scale structural changes independent of biochemical reactions or cytoskeletal disassembly. This concept is consistent with findings that depolymerization of microtubules increases contractility of cells and promotes focal adhesion formation (19), but other evidence suggests that this response is more complex than purely mechanical. Changes in stabilization of microtubules can affect the contraction of the actin-rich cortex of macrophages even at sites so far from the microtubules that a direct mechanical coupling seems unlikely, and the dependence of one filament system on the other may depend more on an as yet unidentified diffusible signal (183). The increased contractility that results when microtubules depolymerize involves increased myosin light-chain phosphorylation, suggesting that chemical changes leading to stronger contraction, in addition to or instead of release of the constraint against contraction, promote the shape change resulting from microtubule depolymerization (115).

	VI. THE CYTOSKELETON AND APOPTOSIS

Top Previous Next References

A hallmark of programmed cell death is an alteration of the cytoskeleton frequently resulting in membrane blebbing (122, 127, 229, 230). It is not yet clear whether these cytoskeletal changes are primarily a result of the activation of proteases and signaling molecules involved in apoptosis, or whether, instead, the reorganization of the cytoskeleton is a necessary event in order for the apoptotic program to proceed. A number of recent experiments suggest that the latter, more active role of the cytoskeleton takes place in at least some cases of apoptosis.

All three cytoskeletal filaments are reorganized or degraded in apoptosis. In lung cancer and neuroblastoma cell lines, cytokeratins and vimentin aggregate and degrade at early stages of apoptosis concomitant with exposure of phosphatidylserine on the cell surface (230). Keratins can also become specifically phosphorylated during apoptosis (132), and experimental aggregation of cytokeratin or vimentin by overexpression of filagrin (46) or intoxication of Sertoli cells by mono-(2-ethylhexyl)phthalate can alter the course of apoptosis (180) without large-scale alteration of either microtubules or F-actin.

A relation between the microtubule system and apoptosis has received particular attention in part because of the clinical importance of tubulin-directed drugs in treatment of human cancers (74, 225). Disruption of microtubule turnover by drugs such as taxol, vincristine, and vinblastine leads to phosphorylation of Raf1 and BCl2 associated with cell death (22, 88). Degradation of tubulin itself can occur during very early stages of apoptosis in neuronal cells treated with glutamate (3). How the disruption of microtubules leads to the later stages of apoptosis is not known, but evidence that diffusible factors may be released as the result of changes in microtubule polymerization (121) is consistent with the hypothesized role of microtubules in sequestering signals in other contexts (115, 183).

The disruption of the actin system during cell death has recently been related to specific changes in actin binding proteins, and a direct link between actin depolymerization and DNA degradation has been suggested. Actin is a prominent substrate for caspases in vitro and in vivo (28, 36, 114, 146), but in several cell types, actin resists cleavage during apoptosis, although it is readily cleaved by interleukin-1-converting enzyme (ICE)-like proteases in vitro (205). Disruption of the actin system by cytochalasin D (190) or sphinxolides (252) can induce apoptosis in cultured cells, suggesting that depolymerization of actin may activate this process. The possibility that destabilizing actin is important for apoptosis is strengthened by the finding that overexpression of the actin monomer binding protein thymosin beta-10 can accelerate apoptosis (90). Furthermore, the actin filament-severing protein gelsolin is cleaved by caspase-3/32-kDa cysteine protease protein (CPP32) to generate a fragment no longer requiring activation by Ca²⁺ that leads to morphological changes in apoptotic cells (116). On the other hand, overexpression of intact gelsolin can inhibit apoptosis and block the activation of CPP32 (160). Cleavage of another actin-associated protein, Gas2, by ICE-like proteases can also activate it to disrupt the actin cytoskeleton (26).

The fact that actin filament pointed ends bind DNase 1 and that ATP-bound monomeric actin is a potent inhibitor of DNase 1 (123, 134, 172) has led to a specific model to relate actin cytoskeleton breakdown to the degradation of nuclear DNA (89, 145, 170). In this scenario, destruction of functional G-actin and loss of filament ends would liberate DNase 1 from the cytoskeleton and permit its entry into the nucleus. Proteins such as thymosins may augment this process (89), and gelsolin can activate actin-inhibited DNase 1 in vitro (50).

Although several lines of evidence show an important link between cytoskeletal integrity and cell viability, the molecular mechanisms for this link are likely to be numerous. In a broad sense, they may separate into two classes of events, either primarily mechanical or chemical. In the latter, signaling molecules or enzymes essential for nuclear or cytoplasmic breakdown are sequestered or inhibited by the cytoskeleton. Disruption of the cytoskeleton by any means would then liberate or activate these sequestered elements and allow them to reach their targets. A more directly mechanical role is suggested by the requirement for appropriately arranged extracellular contacts to prevent cell death (35). In this model, the mechanical tension produced at sites of cell-cell or cell-matrix contact is transmitted by an intact cytoskeleton throughout the cell. Loss of the mechanical integrity of the cytoskeleton would then alter the signals mediated by this tension.

	VII. CYTOSKELETAL ROLE IN SIGNALING TO THE NUCLEUS

Top Previous Next References

The intimate relation between cell shape and gene expression has generally been thought to be mediated in part by the cytoskeleton, since this is probably the only cellular structure directly linking the surface of the cell to the nucleus. Likewise, inhibition of cell growth by contacts is likely to require the cytoskeleton, since cytoskeletal connections enable a mechanical sensing of the number and strength of these adhesions. The particular involvement of the actin system is strongly suggested by the finding that overexpression of several actin-binding proteins that stabilize focal adhesions appears to have antitumerigenic effects that are reviewed in Reference 15, and changes in actin binding protein expression are a common and dramatic feature of transformation by some oncogenes (34, 108, 228).

Three distinct ways in which elements of the cytoskeleton may be involved in nuclear signaling are illustrated in Figure 3. Although the particular examples focus on individual filament types and particular proteins that interact with them, it is important to stress that in vivo these filaments are often extensively intertwined, and perturbations of one system often perturb the structure of the other, usually by mechanisms that are not understood (80).

View larger version (33K): [in this window] [in a new window]   FIG. 3.   Three distinct types of cytoskeletal effects in signaling to the nucleus. PKC, protein kinase C; IF, intermediate filament; MT, microtubule; LEF-1, lymphoid enhancer-binding factor.

A direct cytoskeletal signal is possible because of the continuous link from the nuclear membrane or the nuclear matrix to sites of cell membrane/cytoskeletal anchors mediated most often by IFs (57, 58). This interconnection has been evident for many years, but whether a physical deformation, not mediated by the actions of soluble factors, can regulate gene expression in vivo is an unresolved matter. On the other hand, the physical evidence that such mechanical links exist continues to accumulate. The biochemical features of IF proteins, including their remarkably strong biochemical interactions with sequence-specific DNA, histones, and lipids suggests that such a link may have far-reaching consequences, and two extensive and thoughtful recent reviews make the case for such a possibility (223, 224). This hypothesis is strengthened by the findings that the elastic continuity of the cell persists even when the actin and microtubule systems are destabilized (144) and that there is a mechanical link between desmin IFs and chromatin in cardiac myocytes (24).

Other mechanisms by which cytoskeletal structure may control gene expression are illustrated by two other examples shown in Figure 3. In addition to the requirement for an intact actin cytoskeleton for nuclear targeting of PKC- discussed in section IIB2 (192), a second example of how the actin system may mediate transcription regulation has recently been identified from studies of -catenin, a protein localized at cell-cell contacts by its association with cadherin (1, 86). Although -catenin does not directly bind actin, it is anchored to the cytoskeleton through cadherin and -catenin. Displacement of -catenin from cell-cell contact sites due to mutations in cadherin or to posttranslational modifications of either protein can promote its association with the transcription factor lymphoid enhancer-binding factor (LEF-1) (11), resulting in transport of the -catenin/LEF-1 complex to the nucleus. This finding together with the demonstrations that -catenin binds c-erbB-2 (197) and adenomatous polyposis coli protein (100) and is homologous to Drosophila armadillo protein implicate it in a number of important signaling events (67) that have recently been reviewed (5, 245).

In the previous two examples, activation for transport to the nucleus requires modification of the target protein to release it or translocate it on an intact cytoskeleton. A different mechanism appears to function in the cytoskeletal control of nuclear import of the transcription factor NFB. In the resting cell, NFB is held inactive in the cytoplasm by its association with the inhibitory factor IB. Stability of IB apparently depends on its anchorage to microtubules, possibly by its ankyrin repeat domain (185). When microtubules depolymerize, IB is released, becomes degraded, and releases NFB to allow its nuclear import.

	VIII. CONCLUSIONS

Top Previous Next References

One point that emerges from considering the multitude of factors bound to the cytoskeleton is that aside from matters of spatial sequestration, the functional consequences of this binding may not be evident from the binary reaction alone. Because the cytoskeleton is so large, and its surface area bears a high negative charge density, it can accommodate a large number of structurally diverse molecules and thus act as a catalytic surface as well as a protein cofactor. Membrane-cytoskeleton complexes such as focal adhesions, cell-cell junctions, and caveoli appear to be sites where signaling molecules concentrate to execute a coordinated function, and formation of such complexes may require both proteins and specific lipids. Assembly or release of signaling molecules from cytoskeletal filaments can act to integrate spatially and temporally converging paths of signaling. These features reinforce the necessity to consider signaling as a network of interacting events rather than a linear chain of interactions leading from the plasma membrane to the ultimate target in the cell interior (30, 63, 204).

Perhaps the most intuitively evident potential of the cytoskeleton to control cell function is by direct mechanical coupling between distant points in the cell. There are compelling recent demonstrations that mechanical forces play a vital role in assembling such structures as focal adhesion sites, in regulating ion channels and calcium fluxes, and in controlling nuclear structure and perhaps function. As the methods to measure forces and displacements at the cellular level continue to develop, the relationship between physical effects and cellular function is likely to continue to provide exciting results.

	FOOTNOTES

   Given the large number of publications in this field, important references have inevitably been omitted, and for this I express my regret. I am grateful to Lisa Flanagan for criticism and advice.

   This work was written with support from National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-38910 and Cystic Fibrosis Foundation Grant G957 and was facilitated by the Sigrid Juselius Foundation and the Aspen Center for Physics.

	REFERENCES

Top Previous

1.   ABERLE, H., H. SCHWARTZ, AND R. KEMLER. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell Biochem. 61: 514-523, 1996[Medline].

2.   AKIBA, S., T. SATO, AND T. FUJII. Evidence for an increase in the association of cytosolic phospholipase A₂ with the cytoskeleton of stimulated rabbit platelets. J. Biochem. 113: 4-6, 1993[Abstract/Free Full Text].

3.   ANKARCRONA, M., B. ZHIVOTOVSKY, T. HOLMSTROM, A. DIANA, J. E. ERIKSSON, S. ORRENIUS, AND P. NICOTERA. Lamin and beta-tubulin fragmentation precede chromatin degradation in glutamate-induced neuronal apoptosis. Neuroreport 7: 2659-2664, 1996[Medline].

4.   ARNOLD, H., AND D. PETTE. Binding of aldolase and triosephosphate dehydrogenase to F-actin and modification of catalytic properties of aldolase. Eur. J. Biochem. 15: 360-366, 1970[Medline].

5.   ASSOIAN, R. K., AND X. Y. ZHU. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9: 93-98, 1997[Medline].

6.   BALLMER, H. K., A. ZIEGLER, AND M. M. BURGER. Association of polyoma virus middle T antigen and pp60^src with cytoskeletal elements. Oncogene 3: 365-371, 1988[Medline].

7.   BANNO, Y., S. NAKASHIMA, M. OHZAWA, AND Y. NOZAWA. Differential translocation of phospholipase C isozymes to integrin-mediated cytoskeletal complexes in thrombin-stimulated human platelets. J. Biol. Chem. 271: 14989-14994, 1996[Abstract/Free Full Text].

8.   BANNO, Y., T. NAKASHIMA, T. KUMADA, K. EBISAWA, Y. NONOMURA, AND Y. NOZAWA. Effects of gelsolin on human platelet cytosolic phosphoinositide-phospholipase C isozymes. J. Biol. Chem. 267: 6488-6494, 1992[Abstract/Free Full Text].

9.   BAR, S. D., D. ROTIN, A. BATZER, V. MANDIYAN, AND J. SCHLESSINGER. SH3 domains direct cellular localization of signaling molecules. Cell 74: 83-91, 1993[Medline].

10.   BASSELL, G., AND R. H. SINGER. mRNA and cytoskeletal filaments. Curr. Opin. Cell Biol. 9: 109-115, 1997[Medline].

11.   BEHRENS, J., K. J. VON, M. KUHL, L. BRUHN, D. WEDLICH, R. GROSSCHEDL, AND W. BIRCHMEIER. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642, 1996[Medline].

12.   BEKTAS, M., R. NURTEN, Z. GUREL, Z. SAYERS, AND E. BERMEK. Interactions of eukaryotic elongation factor 2 with actin: a possible link between protein synthetic machinery and cytoskeleton. FEBS Lett. 356: 89-93, 1994[Medline].

13.   BENCHERIF, M., AND R. J. LUKAS. Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton. J. Neurochem. 61: 852-864, 1993[Medline].

14.   BENSIMON, D. Force: a new structural control parameter? Structure 4: 885-889, 1996.

15.   BENZEEV, A.. Cytoskeletal and adhesion proteins as tumor suppressors. Curr. Opin. Cell Biol. 9: 99-108, 1997[Medline].

16.   BERDIEV, B. K., A. G. PRAT, H. F. CANTIELLO, D. A. AUSIELLO, C. M. FULLER, B. JOVOV, D. J. BENOS, AND I. I. ISMAILOV. Regulation of epithelial sodium channels by short actin filaments. J. Biol. Chem. 271: 17704-17710, 1996[Abstract/Free Full Text].

17.   BEREITER, H. J., C. STUBIG, AND V. HEYMANN. Cell cycle-related changes in F-actin distribution are correlated with glycolytic activity. Exp. Cell Res. 218: 551-560, 1995[Medline].

18.   BERK, B. C., M. A. CORSON, T. E. PETERSON, AND H. TSENG. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J. Biomech. 28: 1439-1450, 1995[Medline].

19.   BERSHADSKY, A., A. CHAUSOVSKY, E. BECKER, A. LYUBIMOVA, AND B. GEIGER. Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr. Biol. 6: 1279-1289, 1996[Medline].

20.   BERSHADSKY, A., AND J. VASILIEV. Cytoskeleton. New York: Plenum, 1988.

21.   BHAGYALAKSHMI, A., F. BERTHIAUME, K. M. REICH, AND J. A. FRANGOS. Fluid shear stress stimulates membrane phospholipid metabolism in cultured human endothelial cells. J. Vasc. Res. 29: 443-449, 1992[Medline].

22.   BLAGOSKLONNY, M. V., P. GIANNAKAKOU, AND W. EL. DEIRY, D. G. KINGSTON, P. I. HIGGS, L. NECKERS, AND T. FOJO. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57: 130-135, 1997[Abstract/Free Full Text].

23.   BLOBE, G. C., D. S. STRIBLING, D. FABBRO, S. STABEL, AND Y. A. HANNUN. Protein kinase C betaII specifically binds to and is activated by F-actin. J. Biol. Chem. 271: 15823-15830, 1996[Abstract/Free Full Text].

24.   BLOOM, S., V. G. LOCKARD, AND M. BLOOM. Intermediate filament-mediated stretch-induced changes in chromatin: a hypothesis for growth initiation in cardiac myocytes. J. Mol. Cell. Cardiol. 28: 2123-2127, 1996[Medline].

25.   BOURGUIGNON, L. Y., N. IIDA, AND H. JIN. The involvement of the cytoskeleton in regulating IP₃ receptor-mediated internal Ca²⁺ release in human blood platelets. Cell. Biol. Int. 17: 751-758, 1993[Medline].

26.   BRANCOLINI, C., M. BENEDETTI, AND C. SCHNEIDER. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14: 5179-5190, 1995[Medline].

27.   BRILL, S., S. LI, C. W. LYMAN, D. M. CHURCH, J. J. WASMUTH, L. WEISSBACH, A. BERNARDS, AND A. J. SNIJDERS. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol. Cell. Biol. 16: 4869-4878, 1996[Abstract].

28.   BROWN, S. B., K. BAILEY, AND J. SAVILL. Actin is cleaved during constitutive apoptosis. Biochem. J. 323: 233-237, 1997.

29.   BURRIDGE, K., AND M. CHRZANOWSKA. WODNICKA. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12: 463-518, 1996.[Medline]

30.   BUXBAUM, R.. Biological levels. Nature 373: 567-568, 1995[Medline].

31.   CANTIELLO, H. F.. Role of the actin cytoskeleton on epithelial Na⁺ channel regulation. Kidney Int. 48: 970-984, 1995[Medline].

32.   CANTIELLO, H. F.. Role of the actin cytoskeleton in the regulation of the cystic fibrosis transmembrane conductance regulator. Exp. Physiol. 81: 505-514, 1996[Abstract].

33.   CANTIELLO, H. F., A. G. PRAT, J. V. BONVENTRE, C. C. CUNNINGHAM, J. H. HARTWIG, AND D. A. AUSIELLO. Actin-binding protein contributes to cell volume regulatory ion channel activation in melanoma cells. J. Biol. Chem. 268: 4596-4599, 1993[Abstract/Free Full Text].

34.   CHAPONNIER, C., AND G. GABBIANI. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma. Am. J. Pathol. 134: 597-603, 1989[Abstract].

35.   CHEN, C. S., M. MRKSICH, S. HUANG, G. M. WHITESIDES, AND D. E. INGBER. Geometric control of cell life and death. Science 276: 1425-1428, 1997[Abstract/Free Full Text].

36.   CHEN, Z., M. NAITO, T. MASHIMA, AND T. TSURUO. Activation of actin-cleavable interleukin 1-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res. 56: 5224-5229, 1996[Abstract/Free Full Text].

37.   CHOQUET, D., D. P. FELSENFELD, AND M. P. SHEETZ. Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell 88: 39-48, 1997[Medline].

38.   CHOU, Y. H., O. SKALLI, AND R. D. GOLDMAN. Intermediate filaments and cytoplasmic networking: new connections and more functions. Curr. Opin. Cell Biol. 9: 49-53, 1997[Medline].

39.   CHRZANOWSKA, W. M., AND K. BURRIDGE. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133: 1403-1415, 1996[Abstract/Free Full Text].

40.   CIESIELSKI-TRESKA, J., G. ULRICH, S. CHASSEROT-GOLAZ, AND D. AUNIS. Immunocytochemical localization of protein kinases Yes and Src in amoeboid microglia in culture: association of Yes kinase with vimentin intermediate filaments. Eur. J. Cell Biol. 68: 369-376, 1995[Medline].

41.   CLEGG, J. S.. Intracellular water and the cytomatrix: some methods of study and current views. J. Cell Biol. 99: 167s-171s, 1984[Abstract/Free Full Text].

42.   CONDEELIS, J.. Life at the leading edge: the formation of cell protrusions. Annu. Rev. Cell Biol. 9: 411-444, 1993.

43.   CORNET, M., J. UBL, AND H. A. KOLB. Cytoskeleton and ion movements during volume regulation in cultured PC12 cells. J. Membr. Biol. 133: 161-170, 1993[Medline].

44.   CRAMER, L. P., T. J. MITCHISON, AND J. A. THERIOT. Actin-dependent motile forces and cell motility. Curr. Opin. Cell Biol. 6: 82-86, 1994[Medline].

45.   CUCINA, A., A. V. STERPETTI, G. PUPELIS, A. FRAGALE, S. LEPIDI, A. CAVALLARO, Q. GIUSTINIANI, AND D. L. SANTORO. Shear stress induces changes in the morphology and cytoskeleton organisation of arterial endothelial cells. Eur. J. Vasc. Endovasc. Surg. 9: 86-92, 1995[Medline].

46.   DALE, B. A., R. B. PRESLAND, S. P. LEWIS, R. A. UNDERWOOD, AND P. FLECKMAN. Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity. J. Invest. Dermatol. 108: 179-187, 1997[Medline].

47.   DAVIES, E.. Intercellular and intracellular signals and their transduction via the plasma membrane-cytoskeleton interface. Semin. Cell Biol. 4: 139-147, 1993[Medline].

48.   DAVIES, P. F.. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75: 519-560, 1995[Abstract/Free Full Text].

49.   DAVIES, P. F., K. A. BARBEE, M. V. VOLIN, A. ROBOTEWSKYJ, J. CHEN, L. JOSEPH, M. L. GRIEM, M. N. WERNICK, E. JACOBS, D. C. POLACEK, N. DEPAOLA, AND A. I. BARAKAT. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu. Rev. Physiol. 59: 527-549, 1997[Medline].

50.   DAVOODIAN, K., B. W. RITCHINGS, R. RAMPHAL, AND M. R. BUBB. Gelsolin activates DNase I in vitro and cystic fibrosis sputum. Biochemistry 36: 9637-9641, 1997[Medline].

51.   DEVARAJAN, P., D. A. SCARAMUZZINO, AND J. S. MORROW. Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit. Proc. Natl. Acad. Sci. USA 91: 2965-2969, 1994[Abstract/Free Full Text].

52.   DIAMOND, S. L., F. SACHS, AND W. J. SIGURDSON. Mechanically induced calcium mobilization in cultured endothelial cells is dependent on actin and phospholipase. Arterioscler. Thromb. 14: 2000-2006, 1994[Abstract/Free Full Text].

53.   DORAHY, D. J., L. F. LINCZ, C. J. MELDRUM, AND G. F. BURNS. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem. J. 67-72, 1996.

54.   DROBAK, B. K., P. A. WATKINS, T. D. BUNNEY, S. K. DOVE, P. J. SHAW, I. R. WHITE, AND P. A. MILLNER. Association of multiple GTP-binding proteins with the plant cytoskeleton and nuclear matrix. Biochem. Biophys. Res. Commun. 210: 7-13, 1995[Medline].

55.   EDMONDS, B. T., J. MURRAY, AND J. CONDEELIS. pH regulation of the F-actin binding properties of Dictyostelium elongation factor 1 alpha. J. Biol. Chem. 270: 15222-15230, 1995[Abstract/Free Full Text].

56.   ELS, W. J., AND K. Y. CHOU. Sodium-dependent regulation of epithelial sodium channel densities in frog skin: a role for the cytoskeleton. J. Physiol. (Lond.). 462: 447-464, 1993[Abstract/Free Full Text].

57.   FEY, E. G., D. G. CAPCO, G. KROCHMALNIC, AND S. PENMAN. Epithelial structure revealed by chemical dissection and unembedded electron microscopy. J. Cell Biol. 99: 203s-208s, 1984[Abstract/Free Full Text].

58.   FEY, E. G., K. M. WAN, AND S. PENMAN. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J. Cell Biol. 98: 1973-1984, 1984[Abstract/Free Full Text].

59.   FINCHAM, V. J., M. UNLU, V. G. BRUNTON, J. D. PITTS, J. A. WYKE, AND M. C. FRAME. Translocation of Src kinase to the cell periphery is mediated by the actin cytoskeleton under the control of the Rho family of small G proteins. J. Cell Biol. 135: 1551-1564, 1996[Abstract/Free Full Text].

60.   FISCHER, H., B. ILLEK, AND T. E. MACHEN. The actin filament disrupter cytochalasin D activates the recombinant cystic fibrosis transmembrane conductance regulator Cl channel in mouse 3T3 fibroblasts. J. Physiol. (Lond.) 489: 745-54, 1995[Abstract/Free Full Text].

61.   FISHKIND, D. J., AND Y. L. WANG. New horizons for cytokinesis. Curr. Opin. Cell Biol. 7: 23-31, 1995[Medline].

62.   FORGACS, G.. Biological specificity and measurable physical properties of cell surface receptors and their possible role in signal transduction through the cytoskeleton. Biochem. Cell. Biol. 73: 317-326, 1995[Medline].

63.   FORGACS, G.. On the possible role of cytoskeletal filamentous networks in intracellular signaling: an approach based on percolation. J. Cell Sci. 108: 2131-2143, 1995[Medline].

64.   FROEHNER, S. C.. Regulation of ion channel distribution at synapses. Annu. Rev. Neurosci. 16: 347-368, 1993[Medline].

65.   FUKAMI, K., T. ENDO, M. IMAMURA, AND T. TAKENAWA. alpha-Actinin and vinculin are PIP₂-binding proteins involved in signaling by tyrosine kinase. J. Biol. Chem. 269: 1518-1522, 1994[Abstract/Free Full Text].

66.   FUKAMI, K., K. FURUHASHI, M. INAGAKI, T. ENDO, S. HATANO, AND T. TAKENAWA. Requirement of phosphatidylinositol 4,5-bisphosphate for alpha-actinin function. Nature 359: 150-152, 1992[Medline].

67.   FUNAYAMA, N., F. FAGOTTO, P. MCCREA, AND B. M. GUMBINER. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J. Cell Biol. 128: 959-968, 1995[Abstract/Free Full Text].

68.   FURUKAWA, K., AND M. P. MATTSON. Cytochalasins protect hippocampal neurons against amyloid beta-peptide toxicity: evidence that actin depolymerization suppresses Ca²⁺ influx. J. Neurochem. 65: 1061-1068, 1995[Medline].

69.   FURUKAWA, K., S. V. SMITH, AND M. P. MATTSON. Evidence that actin depolymerization protects hippocampal neurons against excitotoxicity by stabilizing [Ca²⁺]_i. Exp. Neurol. 133: 153-163, 1995[Medline].

70.   FURUKAWA, T., T. YAMANE, T. TERAI, Y. KATAYAMA, AND M. HIRAOKA. Functional linkage of the cardiac ATP-sensitive K⁺ channel to the actin cytoskeleton. Pflügers Arch. 431: 504-512, 1996[Medline].

71.   GACHET, C., B. PAYRASTRE, AND C. GUINEBAULT. C TRUMEL, P. OHLMANN, G. MAUCO, J. P. CAZENAVE, M. PLANTAVID, AND H. CHAP. Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human phosphatidylinositol (3,4)-bisphosphate. J. Biol. Chem. 272: 4850-4854, 1997[Abstract/Free Full Text].

72.   GAERTNER, A., G. W. MAYR, AND A. WEGNER. Binding of sugar phosphates, inositol phosphates and phosphorylated amino acids to actin. Eur. J. Biochem. 198: 67-71, 1991[Medline].

73.   GALLI, A., AND L. J. DEFELICE. Inactivation of L-type Ca channels in embryonic chick ventricle cells: dependence on the cytoskeletal agents colchicine and taxol. Biophys. J. 67: 2296-2304, 1994[Medline].

74.   GANGEMI, R. M., M. TISO, C. MARCHETTI, A. B. SEVERI, AND M. FABBI. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol. 36: 385-392, 1995[Medline].

75.   GILMORE, A., AND K. BURRIDGE. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 381: 531-535, 1996[Medline].

76.   GLANTZ, S. B., Y. LI, AND C. S. RUBIN. Characterization of distinct tethering and intracellular targeting domains in AKAP75, a protein that links cAMP-dependent protein kinase II beta to the cytoskeleton. J. Biol. Chem. 268: 12796-12804, 1993[Abstract/Free Full Text].

77.   GLASER, M., S. WANASKI, C. A. BUSER, V. BOGUSLAVSKY, W. RASHIDZADA, A. MORRIS, M. REBECCHI, S. F. SCARLATA, L. W. RUNNELS, G. D. PRESTWICH, J. CHEN, A. ADEREM, J. AHN, AND S. MCLAUGHLIN. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J. Biol. Chem. 271: 26187-26193, 1996[Abstract/Free Full Text].

78.   GLOGAUER, M., P. ARORA, G. YAO, I. SOKHOLOV, J. FERRIER, AND C. MCCULLOCH. Calcium ions and tyrosine phosphorylation interact coordinately with actin to regulate cytoprotective responses to stretching. J. Cell Sci. 110: 11-21, 1997[Abstract].

79.   GLOGAUER, M., J. FERRIER, AND C. A. MCCULLOCH. Magnetic fields applied to collagen-coated ferric oxide beads induce stretch-activated Ca²⁺ flux in fibroblasts. Am. J. Physiol. 268(Cell Physiol. 37): C1093-C1104, 1995.

80.   GOLDMAN, R. D., S. KHUON, Y. H. CHOU, P. OPAL, AND P. M. STEINERT. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol. 134: 971-983, 1996[Abstract/Free Full Text].

81.   GOLDSCHMIDT, C. P., J. W. KIM, L. M. MACHESKY, S. G. RHEE, AND T. D. POLLARD. Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation. Science 251: 1231-1233, 1991[Abstract/Free Full Text].

82.   GOLDSCHMIDT, C. P., L. M. MACHESKY, J. J. BALDASSARE, AND T. D. POLLARD. The actin-binding protein profilin binds to PIP₂ and inhibits its hydrolysis by phospholipase C. Science 247: 1575-1578, 1990[Abstract/Free Full Text].

83.   GOMEZ, J., AND A. MARTINEZ. DE ARAGON, P. BONAY, C. PITTON, A. GARCIA, A. SILVA, M. FRESNO, F. ALVAREZ, AND A. REBOLLO. Physical association and functional relationship between protein kinase C zeta and the actin cytoskeleton. Eur. J. Immunol. 25: 2673-2678, 1995[Medline].

84.   GRONDIN, P., M. PLANTAVID, C. SULTAN, M. BRETON, G. MAUCO, AND H. CHAP. Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J. Biol. Chem. 266: 15705-15709, 1991[Abstract/Free Full Text].

85.   GUILAK, F.. Compression-induced changes in the shape and volume of the chondrocyte nucleus. J. Biomech. 28: 1529-1541, 1995[Medline].

86.   GUMBINER, B. M., AND P. D. MCCREA. Catenins as mediators of the cytoplasmic functions of cadherins. J. Cell Sci. Suppl. 17: 155-158, 1993[Medline].

87.   HAJNOCZKY, G., C. LIN, AND A. P. THOMAS. Luminal communication between intracellular calcium stores modulated by GTP and the cytoskeleton. J. Biol. Chem. 269: 10280-10287, 1994[Abstract/Free Full Text].

88.   HALDAR, S., A. BASU, AND C. M. CROCE. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57: 229-233, 1997[Abstract/Free Full Text].

89.   HALL, A. K.. Molecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: a hypothesis. Med Hypoth. 43: 125-131, 1994[Medline].

90.   HALL, A. K.. Thymosin beta-10 accelerates apoptosis. Cell. Mol. Biol. Res. 41: 167-180, 1995[Medline].

91.   HARDWICK, J. C., AND R. L. PARSONS. Requirement of a colchicine-sensitive component of the cytoskeleton for acetylcholine receptor recovery. Br. J. Pharmacol. 114: 442-446, 1995[Medline].

92.   HAUSSLER, U., B. M. RIVET, C. FAHLKE, D. MULLER, E. ZACHAR, AND R. RUDEL. Role of the cytoskeleton in the regulation of Cl channels in human embryonic skeletal muscle cells. Pflügers Arch. 428: 323-330, 1994[Medline].

93.   HEIDEMANN, S. R., AND R. E. BUXBAUM. Mechanical tension as a regulator of axonal development. Neurotoxicology 15: 95-107, 1994[Medline].

94.   HELANDER, T. S., O. CARPEN, O. TURUNEN, P. E. KOVANEN, A. VAHERI, AND T. TIMONEN. ICAM-2 redistributed by ezrin as a target for killer cells. Nature 382: 265-268, 1996[Medline].

95.   HELMKE, S., AND K. H. PFENNINGER. Growth cone enrichment and cytoskeletal association of non-receptor tyrosine kinases. Cell. Motil. Cytoskeleton 30: 194-207, 1995[Medline].

96.   HINCHLIFFE, K. A., R. F. IRVINE, AND N. DIVECHA. Aggregation-dependent, integrin-mediated increases in cytoskeletally associated PtdInsP₂ (4,5) levels in human platelets are controlled by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton. EMBO J. 15: 6516-6524, 1996[Medline].

97.   HIRAO, M., N. SATO, T. KONDO, S. YONEMURA, M. MONDEN, T. SASAKI, Y. TAKAI, S. TSUKITA, AND S. TSUKITA. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135: 37-51, 1996[Abstract/Free Full Text].

98.   HOLLANDER, B. A., C. AYYUB, G. SHAW, AND G. S. BENNETT. A neurofilament-associated kinase phosphorylates only a subset of sites in the tail of chicken midsize neurofilament protein. J. Neurochem. 61: 2115-2123, 1993[Medline].

99.   HOVLAND, R., J. HESKETH, AND I. PRYME. The compartmentalization of protein synthesis: importance of cytoskeleon and role in RNA targetting. Int. J. Cell Biol. 28: 1089-1105, 1996.

100.   HULSKEN, J., W. BIRCHMEIER, AND J. BEHRENS. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 2061-2069, 1994.

101.   HWANG, S., D.-Y. JHON, Y. BAE, J. KIM, AND S. RHEE. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J. Biol. Chem. 271: 18342-18349, 1996[Abstract/Free Full Text].

102.   IBARRONDO, J., D. JOUBERT, M. N. DUFOUR, S. A. COHEN, V. HOMBURGER, S. JARD, AND G. GUILLON. Close association of the alpha subunits of G_q and G₁₁ G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation. Proc. Natl. Acad. Sci. USA 92: 8413-8417, 1995[Abstract/Free Full Text].

103.   INGBER, D.. Integrins as mechanochemical transducers. Curr. Opin. Cell Biol. 3: 841-848, 1991[Medline].

104.   INGBER, D.. Tensegrity: the architectural basis of cellular mechanotransduction. Annu. Rev. Physiol. 59: 575-599, 1997[Medline].

105.   INGBER, D. E., AND J. D. JAMIESON. Cells as tensegrity structures: architectural regulation of histodifferentiation by physical forces transduced over basement membrane. In: Gene Expression During Normal and Malignant Differentiation, edited by L. C. Andersson, C. G. Gahmberg, and P. Ekblom. Orlando, FL: Academic, 1985, p. 13-32.

106.   ISHIDA, T., M. TAKAHASHI, M. A. CORSON, AND B. C. BERK. Fluid shear stress-mediated signal transduction: how do endothelial cells transduce mechanical force into biological responses? Ann. NY Acad. Sci. 811: 12-24, 1997.

107.   JANMEY, P. Cell membranes and the cytoskeleton. In: Structure and Dynamics of Membranes. Amsterdam: Elsevier, 1995, p. 805-850.

108.   JANMEY, P., AND C. CHAPONNIER. Medical aspects of the actin cytoskeleton. Curr. Opin. Cell Biol. 7: 111-117, 1995[Medline].

109.   JOHNSON, B. D., AND L. BYERLY. A cytoskeletal mechanism for Ca²⁺ channel metabolic dependence and inactivation by intracellular Ca²⁺. Neuron. 10: 797-804, 1993[Medline].

110.   JOHNSON, B. D., AND L. BYERLY. Ca²⁺ channel Ca²⁺-dependent inactivation in a mammalian central neuron involves the cytoskeleton. Pflügers Arch. 429: 14-21, 1994[Medline].

111.   KAPELLER, R., R. CHAKRABARTI, L. CANTLEY, F. FAY, AND S. CORVERA. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes: potential interactions with the microtubule cytoskeleton. Mol. Cell. Biol. 13: 6052-6063, 1993[Abstract/Free Full Text].

112.   KAPELLER, R., A. TOKER, L. C. CANTLEY, AND C. L. CARPENTER. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin. J. Biol. Chem. 270: 25985-25991, 1995[Abstract/Free Full Text].

113.   KAUFMANN, S., J. KAS, W. H. GOLDMANN, E. SACKMANN, AND G. ISENBERG. Talin anchors and nucleates actin filaments at lipid membranes. A direct demonstration. FEBS Lett. 314: 203-205, 1992[Medline].

114.   KAYALAR, C., T. ORD, M. P. TESTA, L. T. ZHONG, AND D. E. BREDESEN. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 93: 2234-2238, 1996[Abstract/Free Full Text].

115.   KOLODNEY, M. S., AND E. L. ELSON. Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain. Proc. Natl. Acad. Sci. USA 92: 10252-10256, 1995[Abstract/Free Full Text].

116.   KOTHAKOTA, S., T. AZUMA, C. REINHARD, A. KLIPPEL, J. TANG, K. T. CHU, T. J. MCGARRY, M. W. KIRSCHNER, K. KOTHS, D. J. KWIATKOWSKI, AND L. T. WILLIAMS. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298, 1997[Abstract/Free Full Text].

117.   KOZMA, R., S. AHMED, A. BEST, AND L. LIM. The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia. Mol. Cell. Biol. 16: 5069-5080, 1996[Abstract].

118.   KRAUS, F. N.. Signal transduction and calcium: a suggested role for the cytoskeleton in inositol 1,4,5-trisphosphate action. Cell. Motil. Cytoskeleton 28: 279-284, 1994[Medline].

119.   KURASAWA, Y., K. HANYU, Y. WATANABE, AND O. NUMATA. F-actin bundling activity of Tetrahymena elongation factor 1 alpha is regulated by Ca²⁺/calmodulin. J. Biochem. 119: 791-798, 1996[Abstract/Free Full Text].

120.   LANGE, K., AND U. BRANDT. Calcium storage and release properties of F-actin: evidence for the involvement of F-actin in cellular calcium signaling. FEBS Lett. 395: 137-142, 1996[Medline].

121.   LANNI, J. S., S. W. LOWE, E. J. LICITRA, J. O. LIU, AND T. JACKS. p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc. Natl. Acad. Sci. USA 94: 9679-9683, 1997[Abstract/Free Full Text].

122.   LASTER, S. M., AND J. J. MACKENZIE. Bleb formation and F-actin distribution during mitosis and tumor necrosis factor-induced apoptosis. Microsc. Res. Techn. 34: 272-280, 1996.[Medline]

123.   LAZARIDES, E., AND U. LINDBERG. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. Natl. Acad. Sci. USA 71: 4742-4746, 1974[Abstract/Free Full Text].

124.   LEHOTZKY, A., M. TELEGDI, K. LILIOM, AND J. OVADI. Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects. J. Biol. Chem. 268: 10888-10894, 1993[Abstract/Free Full Text].

125.   LEHTONEN, J. Y., AND P. K. KINNUNEN. Phospholipase A₂ as a mechanosensor. Biophys. J. 68: 1888-1894, 1995[Medline].

126.   LETERRIER, J. F., AND J. EYER. Age-dependent changes in the ultrastructure and in the molecular composition of rat brain microtubules. J. Neurochem. 59: 1126-1137, 1992[Medline].

127.   LEVEE, M. G., M. I. DABROWSKA, J. J. LELLI, AND D. B. HINSHAW. Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am. J. Physiol. 271(Cell Physiol. 40): C1981-C1992, 1996[Abstract/Free Full Text].

128.   LEVINA, N. N., R. R. LEW, AND I. B. HEATH. Cytoskeletal regulation of ion channel distribution in the tip-growing organism Saprolegnia ferax. J. Cell Sci. 107: 127-134, 1994[Abstract].

129.   LEVITAN, I., C. ALMONTE, P. MOLLARD, AND S. S. GARBER. Modulation of a volume-regulated chloride current by F-actin. J. Membr. Biol. 147: 283-294, 1995[Medline].

130.   LI, Y., C. NDUBUKA, AND C. S. RUBIN. A kinase anchor protein 75 targets regulatory (RII) subunits of cAMP-dependent protein kinase II to the cortical actin cytoskeleton in non-neuronal cells. J. Biol. Chem. 271: 16862-16869, 1996[Abstract/Free Full Text].

131.   LI, Y., AND C. S. RUBIN. Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton. J. Biol. Chem. 270: 1935-1944, 1995[Abstract/Free Full Text].

132.   LIAO, J., N. O. KU, AND M. B. OMARY. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272: 17565-17573, 1997[Abstract/Free Full Text].

133.   LIN, E. C., AND H. F. CANTIELLO. A novel method to study the electrodynamic behavior of actin filaments. Evidence for cable-like properties of actin. Biophys. J. 65: 1371-1378, 1993[Medline].

134.   LINDBERG, U.. Purification from calf spleen of two inhibitors of deoxyribonuclease. I. Physical and chemical characterization of the inhibitor II. Biochemistry 6: 323-335, 1967[Medline].

135.   LISANTI, M. P., P. E. SCHERER, J. VIDUGIRIENE, Z. TANG, V. A. HERMANOWSKI, Y. H. TU, R. F. COOK, AND M. SARGIACOMO. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126: 111-126, 1994[Abstract/Free Full Text].

136.   LISANTI, M. P., Z. TANG, P. E. SCHERER, E. KUBLER, A. J. KOLESKE, AND M. SARGIACOMO. Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12: 121-124, 1995[Medline].

137.   LIU, G., J. TANG, B. T. EDMONDS, J. MURRAY, S. LEVIN, AND J. CONDEELIS. F-actin sequesters elongation factor 1 from interaction with aminoacyl-tRNA in a pH-dependent reaction. J. Cell Biol. 135: 953-963, 1996[Abstract/Free Full Text].

139.   LUKOWSKI, S., M. C. LECOMTE, J. P. MIRA, P. MARIN, H. GAUTERO, AND F. RUSSO. MARIE, AND B. GENY. Inhibition of phospholipase D activity by fodrin. An active role for the cytoskeleton. J. Biol. Chem. 271: 24164-24171, 1996[Abstract/Free Full Text].

140.   LUO, Z., B. SHAFIT-ZAGARDO, AND J. ERLICHMAN. Identification of the MAP2- and P75-binding domain in the regulatory subunit (RII beta) of type II cAMP-dependent protein kinase. Cloning and expression of the cDNA for bovine brain RII beta. J. Biol. Chem. 265: 21804-21810, 1990[Abstract/Free Full Text].

141.   MACMILLAN, C. L., AND T. M. LINCOLN. High-affinity binding and localization of the cyclic GMP-dependent protein kinase with the intermediate filament protein vimentin. Biochemistry 33: 8035-8043, 1994[Medline].

142.   MAGEE, A. I., AND R. S. BUXTON. Transmembrane molecular assemblies regulated by the greater cadherin family. Curr. Opin. Cell Biol. 3: 854-861, 1991[Medline].

143.   MAINIERO, F., A. PEPE, K. K. WARY, L. SPINARDI, M. MOHAMMADI, J. SCHLESSINGER, AND F. G. GIANCOTTI. Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J. 14: 4470-4481, 1995[Medline].

144.   MANIOTIS, A. J., C. S. CHEN, AND D. E. INGBER. Demonstration of mechanical connections between integrins cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. USA 94: 849-854, 1997[Abstract/Free Full Text].

145.   MANNHERZ, H. G., M. C. PEITSCH, S. ZANOTTI, R. PADDENBERG, AND B. POLZAR. A new function for an old enzyme: the role of DNase I in apoptosis. Curr. Top. Microbiol. Immunol. 198: 161-174, 1995[Medline].

146.   MASHIMA, T., M. NAITO, K. NOGUCHI, D. K. MILLER, D. W. NICHOLSON, AND T. TSURUO. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14: 1007-1012, 1997[Medline].

147.   MASTERS, C.. Interactions between glycolytic enzymes and components of the cytomatrix. J. Cell Biol. 222s-: 225s, 1984.

148.   MAZZANTI, M., R. ASSANDRI, A. FERRONI, AND D. DIFRANCESCO. Cytoskeletal control of rectification and expression of four substates in cardiac inward rectifier K⁺ channels. FASEB J. 10: 357-361, 1996[Abstract].

149.   MCNAMEE, H. P., D. E. INGBER, AND M. A. SCHWARTZ. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121: 673-678, 1993[Abstract/Free Full Text].

150.   MCWHIRTER, J. R., AND J. Y. WANG. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12: 1533-1546, 1993[Medline].

151.   MOGILNER, A., AND G. OSTER. The physics of lamellipodial protrusion. Eur. Biophys. J. 25: 47-53, 1996.

152.   MORISHIMA, K. M., AND K. S. KOSIK. The pool of MAP kinase associated with microtubules is small but constitutively active. Mol. Biol. Cell 7: 893-905, 1996[Abstract].

153.   MUKAI, H., M. TOSHIMORI, H. SHIBATA, H. TAKANAGA, M. KITAGAWA, M. MIYAHARA, M. SHIMAKAWA, AND Y. ONO. Interaction of PKN with alpha-actinin. J. Biol. Chem. 272: 4740-4746, 1997[Abstract/Free Full Text].

154.   MURATA, T., H. KATAGIRI, H. ISHIHARA, Y. SHIBASAKI, T. ASANO, Y. TOYODA, B. PEKINER, C. PEKINER, I. MIWA, AND Y. OKA. Co-localization of glucokinase with actin filaments. FEBS Lett. 406: 109-113, 1997[Medline].

155.   MURRAY, J. W., B. T. EDMONDS, G. LIU, AND J. CONDEELIS. Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends. J. Cell Biol. 135: 1309-1321, 1996[Abstract/Free Full Text].

156.   NAHAS, N., M. PLANTAVID, G. MAUCO, AND H. CHAP. Association of phosphatidylinositol kinase and phosphatidylinositol 4-phosphate kinase activities with the cytoskeleton in human platelets. FEBS Lett. 264: 30-34, 1989.

157.   NEGULYAEV, Y., E. VEDERNIKOVA, AND A. MAXIMOV. Disruption of actin filaments increases the activity of sodium-conducting channels in human myeloid leukemia cells. Mol. Biol Cell. 7: 1857-1864, 1996[Abstract].

158.   NIGGLI, V., C. ANDREOLI, C. ROY, AND P. MANGEAT. Identification of a phosphatidylinositol-4,5-bisphosphate-binding domain in the N-terminal region of ezrin. FEBS Lett. 376: 172-176, 1995[Medline].

159.   OBAR, R., J. DINGUS, H. BAYLEY, AND R. VALLEE. The RII subunit of cAMP-dependent protein kinase binds to a common amino-terminal domain in microtubule-associated proteins 2A, 2B, and 2C. Neuron 3: 639-645, 1989[Medline].

160.   OHTSU, M., N. SAKAI, H. FUJITA, M. KASHIWAGI, S. GASA, S. SHIMIZU, Y. EGUCHI, Y. TSUJIMOTO, Y. SAKIYAMA, K. KOBAYASHI, AND N. KUZUMAKI. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16: 4650-4656, 1997[Medline].

161.   OKAMURA, H., AND M. D. RESH. Differential binding of pp60c-src and pp60v-src to cytoskeleton is mediated by SH2 and catalytic domains. Oncogene 9: 2293-2303, 1994[Medline].

162.   OPSAHL, L. R., AND W. W. WEBB. Transduction of membrane tension by the ion channel alamethicin. Biophys. J. 66: 71-74, 1994[Medline].

163.   OWEN, P. J., G. D. JOHNSON, AND J. M. LORD. Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL60 cells. Exp. Cell Res. 225: 366-373, 1996[Medline].

164.   OZAWA, K., M. TAKAHASHI, AND K. SOBUE. Phase specific association of heterotrimeric GTP-binding proteins with the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. FEBS Lett. 382: 159-163, 1996[Medline].

165.   PAGLIARO, L.. Glycolysis in vivo: fluorescence microscopy as a tool for studying enzyme organization in living cells. Adv. Mol. Cell. Biol. 11: 93-123, 1995.

166.   PAGLIARO, L., AND D. L. TAYLOR. 2-Deoxyglucose and cytochalasin D modulate aldolase mobility in living 3T3 cells. J. Cell Biol. 118: 859-863, 1992[Abstract/Free Full Text].

167.   PAPAKONSTANTI, E. A., D. S. EMMANOUEL, A. GRAVANIS, AND C. STOURNARAS. Na⁺/P_i co-transport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem. J. 241-247, 1996.

168.   PAYRASTRE, B., AND P. VAN BERGEN. EN HENEGOUWEN, M. BRETON, J. DEN HARTIGH, M. PLANTAVID, A. J. VERKLEIJ, AND J. BOONSTRA. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor. J. Cell Biol. 115: 121-128, 1991[Abstract/Free Full Text].

169.   PEI, Z., L. YANG, AND J. R. WILLIAMSON. Phospholipase C-gamma 1 binds to actin-cytoskeleton via its C-terminal SH2 domain in vitro. Biochem. Biophys. Res. Commun. 228: 802-806, 1996[Medline].

170.   PEITSCH, M. C., B. POLZAR, H. STEPHAN, T. CROMPTON, H. R. MACDONALD, H. G. MANNHERZ, AND J. TSCHOPP. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12: 371-377, 1993[Medline].

171.   PIKE, L. J., AND L. CASEY. Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 271: 26453-26456, 1996[Abstract/Free Full Text].

172.   PODOLSKI, J. L., AND T. L. STECK. Association of deoxyribonuclease I with the pointed ends of actin filaments in human red blood cell membrane skeletons. J. Biol. Chem. 263: 638-645, 1988[Abstract/Free Full Text].

173.   POKRYWKA, N. J.. RNA localization and the cytoskeleton in Drosophila oocytes. Curr. Top. Dev. Biol. 31: 139-166, 1995[Medline].

174.   PRAT, A. G., E. J. HOLTZMAN, D. BROWN, C. C. CUNNINGHAM, I. L. REISIN, T. R. KLEYMAN, M. MCLAUGHLIN, G. J. JACKSON, J. LYDON, AND H. F. CANTIELLO. Renal epithelial protein (Apx) is an actin cytoskeleton-regulated Na⁺ channel. J. Biol. Chem. 271: 18045-18053, 1996[Abstract/Free Full Text].

175.   PRAT, A. G., Y. F. XIAO, D. A. AUSIELLO, AND H. F. CANTIELLO. cAMP-independent regulation of CFTR by the actin cytoskeleton. Am. J. Physiol. 267(Cell Physiol. 36): C1552-C1561, 1995.

176.   PREKERIS, R., M. W. MAYHEW, J. B. COOPER, AND D. M. TERRIAN. Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function. J. Cell Biol. 132: 77-90, 1996[Abstract/Free Full Text].

177.   RAMASCHI, G., C. BALDUINI, M. TORTI, AND F. SINIGAGLIA. Effect of cAMP on the association of small GTP-binding proteins with the cytoskeleton of human platelets. Biochim. Biophys. Acta 1199: 20-26, 1994[Medline].

178.   RESNICK, N., AND M. J. GIMBRONE. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 9: 874-882, 1995[Abstract].

179.   RESZKA, A. A., R. SEGER, C. D. DILTZ, E. G. KREBS, AND E. H. FISCHER. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA 92: 8881-8885, 1995[Abstract/Free Full Text].

180.   RICHBURG, J. H., AND K. BOEKELHEIDE. Mono-(2-ethylhexyl)phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol. Appl. Pharmacol. 137: 42-50, 1996[Medline].

181.   ROSALES, C., AND E. J. BROWN. Signal transduction by neutrophil immunoglobulin G Fc receptors. Dissociation of intracytoplasmic calcium concentration rise from inositol 1,4,5-trisphosphate. J. Biol. Chem. 267: 5265-5271, 1992[Abstract/Free Full Text].

182.   ROSALES, C., S. L. JONES, D. MCCOURT, AND E. J. BROWN. Bromophenacyl bromide binding to the actin-bundling protein L-plastin inhibits inositol trisphosphate-independent increase in Ca²⁺ in human neutrophils. Proc. Natl. Acad. Sci. USA 91: 3534-3538, 1994[Abstract/Free Full Text].

183.   ROSANIA, G. R., AND J. A. SWANSON. Microtubules can modulate pseudopod activity from a distance inside macrophages. Cell. Motil. Cytoskeleton 34: 230-245, 1996[Medline].

184.   ROSENMUND, C., AND G. L. WESTBROOK. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10: 805-814, 1993[Medline].

185.   ROSETTE, C., AND M. KARIN. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J. Cell Biol. 128: 1111-1119, 1995[Abstract/Free Full Text].

186.   ROYCHOWDHURY, S., AND M. M. RASENICK. Tubulin-G protein association stabilizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 33: 9800-9805, 1994[Medline].

187.   ROYCHOWDHURY, S., N. WANG, AND M. M. RASENICK. G protein binding and G protein activation by nucleotide transfer involve distinct domains on tubulin: regulation of signal transduction by cytoskeletal elements. Biochemistry 32: 4955-4961, 1993[Medline].

188.   RUBINO, H., M. DAMMERMAN, B. SHAFIT-ZAGARDO, AND J. ERLICHMAN. Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2. Neuron 3: 631-638, 1989[Medline].

189.   SARNDAHL, E., G. M. BOKOCH, O. STENDAHL, AND T. ANDERSSON. Stimulus-induced dissociation of alpha subunits of heterotrimeric GTP-binding proteins from the cytoskeleton of human neutrophils. Proc. Natl. Acad. Sci. USA 90: 6552-6556, 1993[Abstract/Free Full Text].

190.   SAUMAN, I., AND S. J. BERRY. Cytochalasin-D treatment triggers premature apoptosis of insect ovarian follicle and nurse cells. Int. J. Dev. Biol. 37: 441-450, 1993[Medline].

191.   SCHLIWA, M. The Cytoskeleton: An Introductory Survey. Vienna: Springer-Verlag, 1987.

192.   SCHMALZ, D., F. KALKBRENNER, F. HUCHO, AND K. BUCHNER. Transport of protein kinase C  into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not. J. Cell Sci. 109: 2401-2406, 1996[Abstract].

193.   SCHWIEBERT, E. M., J. W. MILLS, AND B. A. STANTON. Actin-based cytoskeleton regulates a chloride channel and cell volume in a renal cortical collecting duct cell line. J. Biol. Chem. 269: 7081-7089, 1994[Abstract/Free Full Text].

194.   SHESTAKOVA, E. A., AND L. P. GAVRILOVA. Effect of cytochalasin D, diphtheria toxin, and ricin on the localization of eukaryotic elongation factor 2 along actin filament bundles in fibroblasts. Dokl. Akad. Nauk. 324: 196-199, 1992[Medline].

195.   SHESTAKOVA, E. A., L. P. MOTUZ, AND L. P. GAVRILOVA. Co-localization of components of the protein-synthesizing machinery with the cytoskeleton in G₀-arrested cells. Cell Biol. Int. 17: 417-424, 1993[Medline].

196.   SHESTAKOVA, E. A., L. P. MOTUZ, A. A. MININ, AND L. P. GAVRILOVA. Study of localization of the protein-synthesizing machinery along actin filament bundles. Cell Biol. Int. 17: 409-416, 1993[Medline].

197.   SHIBATA, T., A. OCHIAI, Y. KANAI, S. AKIMOTO, M. GOTOH, N. YASUI, R. MACHINAMI, AND S. HIROHASHI. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Oncogene 13: 883-889, 1996[Medline].

198.   SHIINA, N., Y. GOTOH, N. KUBOMURA, A. IWAMATSU, AND E. NISHIDA. Microtubule severing by elongation factor 1 alpha. Science 266: 282-285, 1994[Abstract/Free Full Text].

199.   SIMOES, A. P., M. CAMPS, P. SCHNABEL, AND P. GIERSCHIK. Mutational analysis of a putative polyphosphoinositide binding site in phospholipase C-beta 2. FEBS Lett. 365: 155-158, 1995[Medline].

200.   SIMOES, A. P., J. REED, P. SCHNABEL, M. CAMPS, AND P. GIERSCHIK. Characterization of putative polyphosphoinositide binding motifs from phospholipase C beta 2. Biochemistry 34: 5113-5119, 1995[Medline].

201.   SIMOES, A. P., P. SCHNABEL, R. PIPKORN, M. CAMPS, AND P. GIERSCHIK. A peptide corresponding to a potential polyphosphoinositide binding site of phospholipase C-beta 2 enhances its catalytic activity. FEBS Lett. 331: 248-251, 1993[Medline].

202.   SINGH, S. S., A. CHAUHAN, N. MURAKAMI, AND V. P. CHAUHAN. Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry 35: 16544-16549, 1996[Medline].

203.   SMITH, P. R., L. C. STONER, S. C. VIGGIANO, K. J. ANGELIDES, AND D. J. BENOS. Effects of vasopressin and aldosterone on the lateral mobility of epithelial Na⁺ channels in A6 renal epithelial cells. J. Membr. Biol. 147: 195-205, 1995[Medline].

204.   SOBOLEV, A. S., A. R. KAZAROV, AND A. A. ROSENKRANZ. Application of percolation theory principles to the analysis of interaction of adenylate cyclase complex proteins in cell membranes. Mol. Cell. Biochem. 81: 19-28, 1988[Medline].

205.   SONG, Q., T. WEI, M. S. LEES, E. ALNEMRI, D. WATTERS, AND M. F. LAVIN. Resistance of actin to cleavage during apoptosis. Proc. Natl. Acad. Sci. USA 94: 157-162, 1997[Abstract/Free Full Text].

206.   SPUDICH, A., T. MEYER, AND L. STRYER. Association of the beta isoform of protein kinase C with vimentin filaments. Cell. Motil. Cytoskeleton 22: 250-256, 1992[Medline].

207.   SRINIVASAN, Y., M. LEWALLEN, AND K. J. ANGELIDES. Mapping the binding site on ankyrin for the voltage-dependent sodium channel from brain. J. Biol. Chem. 267: 7483-7489, 1992[Abstract/Free Full Text].

208.   STEED, P. M., S. NAGAR, AND L. P. WENNOGLE. Phospholipase D regulation by a physical interaction with the actin-binding protein gelsolin. Biochemistry 35: 5229-5237, 1996[Medline].

209.   STOSSEL, T. P. The machinery of cell crawling. Sci. Am. 271: 54-55, 58-63, 1994.

210.   SYMONS, M., J. M. DERRY, B. KARLAK, S. JIANG, V. LEMAHIEU, F. MCCORMICK, U. FRANCKE, AND A. ABO. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84: 723-734, 1996[Medline].

211.   TAKAI, Y., T. SASAKI, K. TANAKA, AND H. NAKANISHI. Rho as a regulator of the cytoskeleton. Trends Biochem. Sci. 20: 227-231, 1995[Medline].

212.   TANG, J., S. WONG, P. TRAN, AND P. JANMEY. Counterion induced bundle formation of rodlike polyelectrolytes. Ber. Bunsen-Ges. Phys. Chem. 100: 796-806, 1996.

213.   TANG, J. X., AND P. A. JANMEY. The polyelectrolyte nature of F-actin and the mechanism of actin bundle formation. J. Biol. Chem. 271: 8556-8563, 1996[Abstract/Free Full Text].

214.   TAPON, N., AND A. HALL. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9: 86-92, 1997[Medline].

215.   TEMPEL, M., W. H. GOLDMANN, G. ISENBERG, AND E. SACKMANN. Interaction of the 47-kDa talin fragment and the 32-kDa vinculin fragment with acidic phospholipids: a computer analysis. Biophys. J. 69: 228-241, 1995[Medline].

216.   TERRIAN, D. M., AND D. K. WAYS. Persistent enhancement of sustained calcium-dependent glutamate release by phorbol esters: role of calmodulin-independent serine/threonine phosphorylation and actin disassembly. J. Neurochem. 64: 181-190, 1995[Medline].

217.   TERZIC, A., AND Y. KURACHI. Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytes. J. Physiol. (Lond.) 492: 395-404, 1996[Abstract/Free Full Text].

218.   THION, L., C. MAZARS, P. THULEAU, A. GRAZIANA, M. ROSSIGNOL, M. MOREAU, AND R. RANJEVA. Activation of plasma membrane voltage-dependent calcium-permeable channels by disruption of microtubules in carrot cells. FEBS Lett. 393: 13-18, 1996[Medline].

219.   THOMAS, D., S. D. PATTERSON, AND R. A. BRADSHAW. Src homologous and collagen (Shc) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells. J. Biol. Chem. 270: 28924-28931, 1995[Abstract/Free Full Text].

220.   THOUMINE, O.. Control of cellular morphology by mechanical factors. J. Physique 6: 1555-1566, 1996.

221.   TILLMANN, U., AND H. J. BEREITER. Relation of actin fibrils to energy metabolism of endothelial cells. Cell Tissue Res. 243: 579-585, 1986[Medline].

222.   TORTI, M., G. RAMASCHI, F. SINIGAGLIA, E. G. LAPETINA, AND C. BALDUINI. Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation. Proc. Natl. Acad. Sci. USA 90: 7553-7557, 1993[Abstract/Free Full Text].

223.   TRAUB, P.. Intermediate filaments and gene regulation. Physiol. Chem. Phys. Med. NMR 27: 377-400, 1995[Medline].

224.   TRAUB, P., AND R. L. SHOEMAN. Intermediate filament proteins: cytoskeletal elements with gene-regulatory function? Int. Rev. Cytol. 154: 1-103, 1994.

225.   TSUKIDATE, K., K. YAMAMOTO, J. W. SNYDER, AND J. L. FARBER. Microtubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes. Am. J. Pathol. 143: 918-925, 1993[Abstract].

226.   TSUKITA, S., S. YONEMURA, AND S. TSUKITA. ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. Curr. Opin. Cell Biol. 9: 70-75, 1997[Medline].

227.   UNDROVINAS, A. I., G. S. SHANDER, AND J. C. MAKIELSKI. Cytoskeleton modulates gating of voltage-dependent sodium channel in heart. Am. J. Physiol. 268(Heart Circ. Physiol. 37): H203-H214, 1995.

228.   VANDEKERCKHOVE, J., G. BAUW, K. VANCOMPERNOLLE, B. HONORE, AND J. CELIS. Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as one of the most prominent downregulated markers of transformed human fibroblasts and epithelial cells. J. Cell Biol. 111: 95-102, 1990[Abstract/Free Full Text].

229.   VAN DE WATER, B., M. KRUIDERING, AND J. F. NAGELKERKE. F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am. J. Physiol. 270(Renal Fluid Electrolyte Physiol. 39): F593-F603, 1996[Abstract/Free Full Text].

230.   VAN ENGELAND, M., H. J. KUIJPERS, F. C. RAMAEKERS, C. P. REUTELINGSPERGER, AND B. SCHUTTE. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp. Cell Res. 235: 421-430, 1997[Medline].

231.   VAN ESSEN, D.. A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature 385: 313-318, 1997[Medline].

232.   VAN ETTEN, R., P. K. JACKSON, D. BALTIMORE, M. C. SANDERS, P. T. MATSUDAIRA, AND P. A. JANMEY. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124: 325-340, 1994[Abstract/Free Full Text].

233.   VAN HAELST, C., AND T. L. ROTHSTEIN. Cytochalasin stimulates phosphoinositide metabolism in murine B lymphocytes. J. Immunol. 140: 1256-1258, 1988[Abstract].

234.   VAZIRI, C., AND C. P. DOWNES. Association of a receptor and G-protein-regulated phospholipase C with the cytoskeleton. J. Biol. Chem. 267: 22973-22981, 1992[Abstract/Free Full Text].

235.   VERREY, F., P. GROSCURTH, AND U. BOLLIGER. Cytoskeletal disruption in A6 kidney cells: impact on endo/exocytosis and NaCl transport regulation by antidiuretic hormone. J. Membr. Biol. 145: 193-204, 1995[Medline].

236.   VICKERS, J. D., R. KINLOUGH-RATHBONE, AND J. F. MUSTARD. Phosphatidylinositol 4,5-bisphosphate is selectively retained by platelet-fibrin clots formed by thrombin. Biochem. J. 245: 649-653, 1987[Medline].

237.   VOLKER, K. W., C. A. REINITZ, AND H. R. KNULL. Glycolytic enzymes and assembly of microtubule networks. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 112: 503-514, 1995[Medline].

238.   WANG, J., A. J. MORRIS, D. R. TOLAN, AND L. PAGLIARO. The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J. Biol. Chem. 271: 6861-6865, 1996[Abstract/Free Full Text].

239.   WANG, N., J. P. BUTLER, AND D. E. INGBER. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124-1127, 1993[Abstract/Free Full Text].

240.   WANG, W. H., A. CASSOLA, AND G. GIEBISCH. Involvement of actin cytoskeleton in modulation of apical K channel activity in rat collecting duct. Am. J. Physiol. 266(Renal Fluid Electrolyte Physiol. 35): F592-F598, 1994[Abstract/Free Full Text].

241.   WATSON, A. J., S. LEVINE, M. DONOWITZ, AND M. H. MONTROSE. Serum regulates Na⁺/H⁺ exchange in Caco-2 cells by a mechanism which is dependent on F-actin (published erratum appears in J. Biol. Chem. 268: 3016, 1993) J. Biol. Chem. 267: 956-962, 1992.

242.   WEERNINK, P. A., AND G. RIJKSEN. Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J. Biol. Chem. 270: 2264-2267, 1995[Abstract/Free Full Text].

243.   WIELAND, T., AND D. MEYER. ZU HERINGDORF, R. A. SCHULZE, S. KALDENBERG-STASCH, AND K. H. JAKOBS. Receptor-induced translocation of activated guanine-nucleotide-binding protein alpha i subunits to the cytoskeleton in myeloid differentiated human leukemia (HL-60) cells. Eur. J. Biochem. 239: 752-758, 1996[Medline].

244.   WILLIAMS, D. S., S. PARK, C. L. SCHLAMP, AND A. C. NEWTON. Protein kinase C association with the retinal cytoskeleton and phosphorylation of vimentin. Exp. Eye Res. 58: 747-759, 1994[Medline].

245.   YAMADA, K. M., AND B. GEIGER. Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol. 9: 76-85, 1997[Medline].

246.   YAN, S. R., L. FUMAGALLI, AND G. BERTON. Activation of SRC family kinases in human neutrophils. Evidence that p58C-FGR and p53/56LYN redistributed to a Triton X-100-insoluble cytoskeletal fraction, also enriched in the caveolar protein caveolin, display an enhanced kinase activity. FEBS Lett. 380: 198-203, 1996[Medline].

247.   YANG, F., M. DEMMA, V. WARREN, S. DHARMAWARDHANE, AND J. CONDEELIS. Identification of an actin-binding protein from Dictyostelium as elongation factor 1. Nature 347: 494-496, 1990[Medline].

248.   YANG, W., AND W. F. BOSS. Regulation of phosphatidylinositol 4-kinase by the protein activator PIK-A49. Activation requires phosphorylation of PIK-A49. J. Biol. Chem. 269: 3852-3857, 1994[Abstract/Free Full Text].

249.   YU, F. X., H. Q. SUN, P. A. JANMEY, AND H. L. YIN. Identification of a polyphosphoinositide-binding sequence in an actin monomer-binding domain of gelsolin. J. Biol. Chem. 267: 14616-14621, 1992[Abstract/Free Full Text].

250.   ZALEWSKI, P. D., I. J. FORBES, C. GIANNAKIS, AND W. H. BETTS. Regulation of protein kinase C by Zn²⁺-dependent interaction with actin. Biochem. Int. 24: 1103-1110, 1991[Medline].

251.   ZALEWSKI, P. D., I. J. FORBES, C. GIANNAKIS, P. A. COWLED, AND W. H. BETTS. Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton. FEBS Lett. 273: 131-134, 1990[Medline].

252.   ZHANG, X., L. MINALE, A. ZAMPELLA, AND C. D. SMITH. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides. Cancer Res. 57: 3751-3758, 1997[Abstract/Free Full Text].

253.   ZIGMOND, S. H.. Signal transduction and actin filament organization. Curr. Opin. Cell Biol. 8: 66-73, 1996[Medline].

0031-9333/98 $15.00 Copyright ©1998 The American Physiological Society